GRRMF (Gerresheimer AG) Marketable Securities: $17 Mil (As of Nov. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

GRRMF Gerresheimer AG GRRMF
58 GF Score
Price $33.35
GF Value $190.12
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Gerresheimer AG Marketable Securities?

Gerresheimer AG GRRMF 58 Marketable Securities is $17 Mil as of Nov. 2025. GuruFocus rates GRRMF with a GF Score™ of 58/100 and a GF Value™ of $190.12 (Possible Value Trap). The stock has 6 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Gerresheimer AG's Marketable Securities for the quarter that ended in Nov. 2025 was $17 Mil.

Gerresheimer AG's annual Marketable Securities increased from Nov. 2023 ($23 Mil) to Nov. 2024 ($28 Mil) but then declined from Nov. 2024 ($28 Mil) to Nov. 2025 ($17 Mil).

Gerresheimer AG  (OTCPK:GRRMF) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Gerresheimer AG Marketable Securities Related Terms

Gerresheimer AG Marketable Securities Historical Data

* Premium members only.

The historical data trend for Gerresheimer AG's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gerresheimer AG Marketable Securities Chart

Gerresheimer AG Annual Data
Trend Nov16 Nov17 Nov18 Nov19 Nov20 Nov21 Nov22 Nov23 Nov24 Nov25
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 18.54 12.28 22.93 28.32 17.01

Gerresheimer AG Quarterly Data
Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 28.32 34.45 29.32 31.78 17.01
GRRMF
58GF Score
Gerresheimer AG GRRMF
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Gerresheimer AG Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of $17 Mil mean?
Gerresheimer AG (GRRMF) has a Marketable Securities of $17 Mil as of Nov. 2025. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Gerresheimer AG and its competitors.
Is Gerresheimer AG's Marketable Securities too high?
Gerresheimer AG's current Marketable Securities is $17 Mil. Overall, Gerresheimer AG has a GF Score™ of 58/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Gerresheimer AG's Marketable Securities compare to ISRG and BDX?
Gerresheimer AG's Marketable Securities of $17 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Medical Devices & Instruments company?
A good Marketable Securities depends on the Medical Devices & Instruments industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Gerresheimer AG and its competitors. Gerresheimer AG's current Marketable Securities is $17 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gerresheimer AG stock overvalued right now?
Based on GuruFocus' analysis, Gerresheimer AG (GRRMF) is currently considered Possible Value Trap. The stock's GF Value™ is $190.12, compared to a current price of $33.35 — trading 82.5% below its estimated fair value. The current Marketable Securities is $17 Mil. Gerresheimer AG's overall GF Score™ is 58/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Gerresheimer AG (GRRMF), the current Marketable Securities is $17 Mil as of Nov. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Gerresheimer AG (GRRMF) Overvalued in 2026?

Based on GuruFocus' analysis, Gerresheimer AG stock appears to be undervalued. The current stock price of $33.35 is trading 82.5% below its estimated GF Value™ of $190.12. GuruFocus considers Gerresheimer AG to be Possible Value Trap.

Key valuation signals for GRRMF:

  • Marketable Securities: $17 Mil
  • GF Value™: $190.12 vs. price of $33.35 (82.5% below fair value)
  • GF Score™: 58/100 with 6 warning signs

No single metric tells the full story. See the GRRMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Gerresheimer AG Business Description

Address Klaus-Bungert-Strasse 4, Duesseldorf, NW, DEU, 40468
Gerresheimer AG provides medicine packaging, drug delivery devices, and solutions with a product range for pharma, health, well-being, and biotech. The firm operates in three segments: The plastics and devices segment consists of products for simple and safe drug delivery along with packaging for liquid and solid medicines, The primary packaging glass segment produces glass packaging products for the pharma and cosmetics industries also for food and beverage industry and The advanced technologies segment works on technical and digital solutions to improve the therapy outcome for patients. The company generates the majority of its revenue in Europe, with sales in Germany contributing the major proportion of any country.
58GF Score

Get the complete analysis for GRRMF

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$33.35
Price
$190.12
GF Value